Skip to Main Content
TRC_PL_NEW
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Student Resources
    • Faculty Resources
    • Journal Club
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Antidepressants
    • Contraceptives
    • Diabetes Drugs
    • Do Not Crush List
    • First Time Generics
    • New Drugs
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New Podcast CE Alert: "Medications for Opioid Use Disorder" is now available! Listen for FREE now. Subscribers can earn CE credits just for listening and passing a short quiz.
Become a smarter pharmacist in minutes! More CE, more resources, more value. Choose your Pharmacist's Letter membership and elevate your pharmacy practice today. Subscribe Now
  1. Home
  2. Browse
  3. Hematology & Oncology
  4. Resources
  5. Guidelines

Guidelines

  • Anemia (53)
  • Blood Products (5)
  • Breast Cancer (65)
  • Cancer (22)
  • Cervical Cancer (18)
  • Chemotherapy (6)
  • Chemotherapy-Induced Adverse Effects (35)
  • Colon Cancer (22)
  • Drugs/Products That May Increase Cancer Risk (119)
  • Gastrointestinal Cancers (33)
  • Hemophilia (4)
  • Hemorrhage (7)
  • Leukemia (1)
  • Lung Cancer (98)
  • Lymphoma & Multiple Myeloma (1)
  • Ovarian Cancer (5)
  • Prostate Cancer (29)
  • Renal Cancer (1)
  • Resources (76)
    • Charts (11)
    • Drugs (6)
    • Guidelines (3)
    • Letters (5)
    • Natural Medicines / Supplements (22)
    • Patient Education (5)
    • PL Voices (34)
    • Quality Measures (13)
  • Sickle Cell Disease (5)
  • Skin Cancer (23)
1 - 3 of 3 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Guideline: Use of 5-alpha Reductase Inhibitors for Prostate Cancer Chemoprevention (2008) August 2011
Commentary: Possible Increased Risk of Aggressive Prostate Cancer with Finasteride and Dutasteride August 2011
Guideline: Prevention and Treatment of Mucositis (2007) November 2009
  • 1
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved